# Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

> **NCT00003942** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Systemix** · enrollment: 15 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** RevM10 gene
- **BIOLOGICAL:** RevM10/polAS gene
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003942
- **Lead sponsor:** Systemix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2013-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003942, "Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00003942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*